• Multilayered absorbent dressing conforms to the skin and wound
• Contains a layer of polyurethane foam, a non-woven layer of Hydrofiber® (sodium carboxymethylcellulose) and a perforated silicone adhesive wound contact layer
• Outer film layer provides a waterproof viral and bacterial barrier which protects the wound from external contaminants, reducing the risk of infection
• Film also helps to manage the moisture vapor transmission of the exudate absorbed by the dressing
• Foam and Hydrofiber® materials within the dressing absorb high amounts of wound fluid and bacteria
• Hydrofiber® layer helps maintain a moist environment in the wound (which supports the body's healing process) and aids in the removal of non-viable tissue from the wound (autolytic debridement) without damaging tissue
• Silicone adhesive wound contact layer provides secure, skin-friendly, gentle adhesion
AQUACEL® Foam Pro dressings may be used for the management of both chronic and acute wounds, such as leg ulcers, pressure injuries (stages 2-4) and diabetic ulcers; surgical wounds (post-operative, donor sites, dermatological); partial-thickness (second-degree) burns; traumatic or surgical wounds left to heal by secondary intention such as dehisced surgical incisions; surgical wounds that heal by primary intent, such as dermatological and surgical incisions (e.g., orthopedic and vascular); local management of wounds that are prone to bleeding, such as wounds that have been mechanically or surgically debrided and donor sites; abrasions; lacerations; minor cuts.
AQUACEL® Foam Pro dressing may be included in a comprehensive protocol of care to protect against skin breakdown.
AQUACEL® Foam Pro dressings should not be used on individuals who are sensitive to or who have had an allergic reaction to the dressing or its components.
Sterility is guaranteed unless pouch is damaged or opened prior to use.
This device is for single use only and should not be reused. Reuse may lead to increased risk of infection or cross-contamination. Physical properties of the dressing may no longer be optimal for intended use. This wound dressing should not be used with other wound care products without first consulting a health care professional.
During the body's normal healing process, non-viable tissue may be removed (autolytic debridement) from the wound, which could make the wound appear larger after the first few dressing changes.
Should you observe irritation (reddening, inflammation), maceration (whitening of skin) or hypergranulation (excess tissue formation), consult a health care professional.
The wound should be inspected during dressing changes for (1) signs of infection (increased pain, bleeding, warmth/redness of surrounding tissue, wound exudate), (2) changes in wound color and/or odor, (3) any other unexpected symptoms (e.g., maceration or hypergranulation).
The use of AQUACEL® Foam Pro dressing has not been studied in wounds due to herpes simplex or impetigo.
For leg ulcers, pressure injuries, diabetic ulcers, second-degree burns, donor sites, surgical or traumatic wounds left to heal by primary or secondary intention:
• Treatment of the wound types listed above should only be under the supervision of a health care professional.
• Appropriate supportive measures should be taken where indicated (e.g., use of graduated compression bandaging in the management of venous leg ulcers or pressure relief measures in the management of pressure injuries).
• Colonization of chronic wounds is common and is not a contraindication to the use of the dressing. The dressing may be used on infected wounds under medical supervision together with appropriate therapy and frequent monitoring of the wound.
• The control of blood glucose, as well as appropriate supportive measures, should be provided to patients with diabetic foot ulcers.
AQUACEL® Foam Pro dressings are not compatible with oil-based products or emollients such as petrolatum.
Do not use AQUACEL® Foam Pro dressings with oxidizing agents such as hydrogen peroxide or hypochlorite solutions.
The use of dressings as part of a prophylactic therapy does not preclude the need to continue to develop and follow a comprehensive protocol of care to protect against skin breakdown (i.e., support surfaces, positioning, nutrition, hydration, skin care and mobility).
Store at room temperature (10°C- 25°C, 50°F-77°F). Protect from light. Keep dry.
|Antimicrobial format available|
|Compatible w/ topicals||●|
|Intact when saturated||●|
|Moisture vapor permeable||●|
|Secondary dressing required|
|Usable on infected wounds||●|
|Variety of sizes||●|
Moderate/Highly Exudating Wounds
Choose a dressing size to ensure that the central absorbent pad is 1cm larger than the wound area. Remove the dressing from the sterile pack, minimizing finger contact with the adhesive surface where applicable. Remove the release liner. The dressing can be cut to shape for convenience. Hold the dressing over the wound or area of skin to be protected, and line up the center of the dressing with the center of the wound or area of skin to be protected. Place the pad directly over the wound and smooth down the adhesive border. An appropriate retention bandage or tape should be used to secure the dressing in place if required or if the dressing has been cut. Discard any unused portion of the product after dressing the wound.
The dressing should be changed when clinically indicated (i.e., leakage, bleeding, increased pain, suspicion of infection). Maximum recommended wear time is seven days. The wound should be cleansed at appropriate intervals. To remove the dressing, press down gently on the skin and carefully lift one corner of the dressing. Continue until all edges are free. Carefully lift away the dressing and discard according to local clinical protocols.
ConvaTec is a global medical device and technologies company focused on therapies for the management of acute and chronic wounds, with a leading market position in advanced wound care. ConvaTec products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care.